Denileukin Diftitox in Combination with Rituximab for Previously Untreated Follicular B-cell Non-Hodgkin’s Lymphoma

Follicular lymphoma exhibits intratumoral infiltration by non-malignant T lymphocytes inluding CD4+CD25+ regulatory T (T(reg)) cells. We combined denileukin diftitox with rituximab in previously untreated, advanced-stage follicular lymphoma patients anticipating that denileukin diftitox would deplet...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ansell, Stephen M., Tang, Hui, Kurtin, Paul J., Koenig, Patricia A., Nowakowski, Grzegorz S., Nikcevich, Daniel A., Nelson, Garth D., Yang, Zhizhang, Grote, Deanna M., Ziesmer, Steven C., Silberstein, Peter T., Erlichman, Charles, Witzig, Thomas E.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3266999/
https://ncbi.nlm.nih.gov/pubmed/22015775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2011.297
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items